IntelligentMDx (IMDx), Cambridge, Mass, will present development and performance data for four high-throughput, automated, molecular diagnostic tests at the Association for Molecular Pathology (AMP) 2012 Annual Meeting.
The meeting takes placein Long Beach, Calif, from October 24 to 27. The AMP meeting is an opportunity for experts from a variety of clinical, laboratory, and medical fields to engage in discussions surrounding diagnostic, prognostic, and therapeutic approaches in molecular pathology.
The IMDx presentations are in the Infectious Disease category and highlight the design, development, and performance of four infectious disease assays: the CE-marked IMDx C. difficile for Abbott m2000, IMDx VanR for Abbott m2000, and IMDx HSV-1/2 for Abbott m2000 assays, and the IMDx Flu A/B and RSV for Abbott m2000 assay, which is anticipated to receive CE-marking in 2013.
[source: IntelligentMDx]
